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Abstract. Epilepsy is the expression of a functional paroxysmal neural impulses disturbance 
where neurons discharge excessive nerve impulses with a high frequency and abnormal synchrony. 
Investigations were conducted on a total of 45 dogs diagnosed with epilepsy aged between 3 months 
and 10 years. A number of 40 clinically healthy dogs were controll group (group M). Were determined 
plasma and erythrocyte magnesium, calcium, inorganic phosphate,  potassium and sodium by 
molecular absorption spectrophotometry (colorimetric methods). In dogs with primary and secondary 
epilepsy has recorded a negative balance of magnesium with a statistically significant decrease of 
plasma and erythrocyte magnesium and also a negative correlation between attacks frequency-plasma 
and erythrocyte magnesium; the dogs with status epilepticus recorde the lowest levels of plasma and 
erythrocyte magnesium. The hypomagnesaemia, hypocalcemia and hyperphosphatemia recorded in 
dogs with secondary epilepsy are the important biochemical changes of magnesium deficiency 
syndrome with neuromusculare symptoms. 
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INTRODUCTION 
 
Epilepsy in animals has been described by the similarity with what is found in 
humans. The disease is present in all breeds of dogs, including mixed breed. Incidence is 
estimated at 5-5.5% and at certain breeds can climb to 14-21% (ex. Belgian Tervuren, 
Beagles, Vizsla) (Cunningham, 1987; Koestner, 1989; Oliver, 1993; Thomas, 2000). 
Many studies have highlighted the existence of a relationship between lower 
magnesium levels in the body and epilepsy. Plasma magnesium concentration may be 
intermittently normal while erythrocyte magnesium concentration is consistently low in 
humans. 
The aim of this study was to highlight the involvement of magnesium in canine 
epilepsy. 
 
MATERIALS AND METHODS 
 
The research was conducted on a total of 45 dogs diagnosed with epilepsy aged 
between 3 months and 10 years. The patients were investigated in the Internal  Diseases 
Clinic of Faculty of Veterinary Medecine Cluj. The diagnosis was established through a series 
of laboratory testes.  30 of the patients taken in study were diagnosed with primary epilepsy 
(true epilepsy) (A group) and 15 patients with secondary epilepsy (symptomatic epilepsy) (B 
group). A number of 40 clinically healthy dogs were control group (M group).  
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Blood samples were taken by venous puncture in Li-heparin tubes. Were established 
plasma and erythrocyte magnesium, calcium, inorganic phosphate, potassium and sodium by 
molecular absorption spectrophotometry (colorimetric methods) with semiautomatic analyzer 
Screen Master Plus and reagents supplied by HOSPITEX Diagnostics Italy. The researches 
have received an indirect calculation technique of erythrocyte magnesium by formula: 
MgP
H
MgPMgTMgE +×−= 100)(   
where MgE= erythrocyte magnesium, MgT= total magnesium, MgP= plasma magnesium and 
H= PCV= packed cell volume. The results are expreesed in mg/dl, mEq/l or mmol/l.  
 
RESULTS AND DISCUSSIONS 
 
Biochemical results in relation to the type of epilepsy are presented in table 1.   
A significant statistically decrease recorded the plasma and erythrocyte magnesium 
values (p<0.001) in two epileptic groups compared controll group (graph 1). In relation to the 
frequency of attacks the levels of plasma and erythrocyte magnesium decrease as the attacks 
became more frequent (table 2, graph 2). A number of 10 in B group (secondary epilepsy) had 
significantly elevated levels of phosphatemia (p<0.001) and extremely low levels of plasma 
magnesium, erythrocyte magnesium and calcium (p<0.001) compared controll group. They 
were the C group.  
 
Tab. 1 
The values of the mineral constituents in relation to the type of epilepsy 
 
Constituent (x±s) 
Group 
PMg mmol/l EMg  
mmol/l 
Ca  
mmol/l 
P  
mmol/l 
K  
mmol/l 
Na  
mmol/l 
A group  0,54±0,10 1,01±0,21 2,53±0,13 1,52±0,28 3,54±0,18 126,57±5,0 
B group  0,52±0,12 0,93±0,28 2,56±0,28 1,79±0,21 3,52±0,20 130±4,53 
M group 0,91±0,03 2,74±0,10 2,74±0,12 1,53±0,20 4,02±0,27 140±4,03 
„t” test A-B   NS NS NS p<0,001 NS NS 
„t” test A-M   p<0,001 p<0,001 p<0,001 NS p<0,01 p<0,05 
 
Analysing the obtained results is established that canine epilepsy is characterised by 
erythrocyte and plasma hypomagnesemia. This appearance confirms magnesium intervention 
in canine epilepsy, not only in humans epilepsy. Other similar views is difficult to specify if 
hypomagnesaemia participate as triggers in genesis of atacks or secondary nerve disorders. 
Currently in epileptic children is widely accepted existance of a plasma and erythrocyte 
magnesium signficant decreases (Durlach and col., 1993; Durlach and col., 1997; Miu and 
Dragotoiu, 2000). According to Miu (2000),magnesium is considered as an resistance element  
in convulsive events of epilepsy: how magnesium deficiency is expressed even clinical 
expression is more serious. 
In front study there is a negative correlation between a number of attacks and 
magnesaemia: plasma and erythrocyte magnesium levels decreases as the frequency of attacks 
increases (table 3, graph 3). The lower values are recorded at subjects with epileptic status: 
0.33±0.08 mmol/l. At the opposite pole were placed the subjects , with rare attacks (more one 
month): 0.69±0.09 mmol/l. The erythrocyte magnesium concentration is cvasiconstant low 
relatively to plasma one, inclusively at subjects with rare attacks: 1.81±0.15 mmol/l. Durlach 
and col. (1993) identify this phenomenon in epileptic rats. 
 57 
 
0
0.5
1
1.5
2
2.5
3
PMg EMg
A group
B group
M group
 
Graph 1. Differences significance for the plasma (PMg) and erythrocyte magnesium (EMg) between the epileptic 
dogs groups and the controll group (M group) 
 
Tab. 2 
The values of the seric and erythrocyte magnesium in relation to the frequency of attacks 
 
Constituent (x ± s) The frequency of attacks 
PMg (mmol/l) EMg (mmol/l) 
Rarely attacks (period longer more than month)  0,69 ± 0,09 1,81 ± 0,15 
Freq.attacks (one for week→one for month) 0,57 ± 0,07  1,43 ± 0,08 
Very freq.attacks (more for day→one for week) 0,46 ± 0,09 1,15 ± 0,07 
Status epilepticus 0,33 ± 0,08 0,66 ± 0,07 
Controll group (M) 0,91 ± 0,03 2,74 ± 0,10 
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Graph 2. The levels of the plasma (PMg) and erythrocyte magnesium (EMg) in relation to the frequency of 
attacks 
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Provided statistically lower values of calcium and sodium was found in epileptic dogs. 
Calcium and magnesium deficiency are expressed by hyperexcitability which in serious forms 
can even induce attacks. Moderate hypocalcemia evolves as a secondary phenomenon of 
hypomagnesaemia (Zeana, 1994). Calcium decrease is more evident in 10 subjects with 
secondary epilepsy group: 2.44±0.10 mmol/l. They were the C group (table 3). 
Zimmet and col. (cit. by Zeana, 1994) pleds to calcium decreased as a consequence of 
hypomagnesaemia. Decrease of calcium in C group is accompanied by increase of inoganic 
phosphate values over the range references: 1.94±0.19 mmol/l C group to 1.53±0.20 mmol/l 
M group (p<0.001). Durlach and col. (1997) confirm in his studies that the magnesium 
deficiency is characterized by normal or low calcemia and phosphatemia values over the 
range references. Magnesium and inorganic phosphate are antagoniste roles in neuromuscle 
physiology: magnesium along with calcium decreased neuromuscle excitability while 
inorganic phosphate  increased it.  
 
Tab. 3 
The mineral constituents values in dogs from lot C 
 
Constituent (x ± s)  Cases 
number  
Age 
MgP  
(mmol/l) 
MgE 
(mmol/l) 
Ca 
(mmol/l) 
P 
(mmol/l) 
1. 7 months 0,46 0,82 2,74 1,94  
2. 7 months 0,49 0,81 2,40 1,89 
3. 3 ages 0,47 0,87 2,56 1,90 
4. 2 ages  0,51 1,00 2,52 2,01 
5. 3 months 0,45 0,66 2,20 1,95 
6. 1 age 0,41 0,80 2,07 1,94 
7. 9 months  0,56 0,83 2,37 1,97 
8. 1 age 0,55 1,03 2,45 1,92 
9. 8 months   0,60 1,15 2,57 1,97 
10. 9 months 0,57 0,98 2,52 1,90 
x ± s 0,51± 0,17  0,89± 0,19 2,44± 0,10 1,94± 0,19  
M group  0,91 ± 0,03 2,74 ± 0,10 2,74 ± 0,12 1,53 ± 0,20 
„t”test C-M group  p<0,001 p<0,001 p<0,001 p<0,001 
 
At dogs from C group unexisting the elements of a renale failure with phosphates 
retract, must be admitted that plasma and erythrocyte hypomagnesemia accompanied by 
hypocalcemia and hyperphosphatemia are constituted like biochemical disturbances of a 
magnesium deficiency syndrom with neuromuscle implications, which one element is 
secondary epilepsy. 
Some authors (Miu and Dragotoiu, 2000) belive these changes raise th issue of a 
hypoparathiroidism. But it is accompanied a severe hypocalcemia:1.52±0.97 mmol/l and 
hyperphosphatemia: 1.93 mmol/l without hypomagnesaemia (Ghergariu, 1995).  
Relatively low potassium and sodium plasma concentrations in epileptic dogs are 
secondary to magnesium deficiency. Magnesium deficiency is accompanied by potassium 
loses through the exit of cells and followed by a sodium overload (Crayton, 1981; Collins, 
1994; Thomas, 2000).  That  low values can be attributed to involuntary broadcast of urine 
during attacks. 
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Graph 3. Differences significance for the mineral constituents: plasma magnesium (PMg), erythrocyte 
magnesium (EMg), calcium (Ca), phosphate (P), between C and M group 
 
In conclusion, the plasma and erythrocyte hypomagnesemia established in this study is 
an important biochemical disturbance in canine epilepsy. 
 
CONCLUSIONS 
 
1. Canine primary and secondary epilepsy be accompanied by negative survey of magnesium 
with a statistically significant decrease of plasma and erythrocyte magnesium. 
2. Was showing a negative correlation between the comitial crises of plasma and erythrocyte 
magnesium. 
3. Magnesium deficiency entails a realtive diminution of plasma potassium and sodium 
values in  primary and secondary epilepsy in dogs taken in the study. 
4. Hypomagnesemia, hypophosphatemia and hypocalcemia recorded in the epileptic dogs  
from C group, to be performed important biochemical changes of the magnesium 
deficiency syndrome with neuromuscle symptoms. 
5. Plasma and erythrocyte hypomagnesemia, as important biochemical changes in canine 
epilepsy, advocating for the introduction of magnesium status assessment in the laboratory 
tests. 
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